TVAMP
ARMP icon

Tennessee Valley Asset Management Partners’s Armata Pharmaceuticals ARMP Stock Holding History

Tennessee Valley Asset Management Partners’s Portfolio ARMP Stock Details ARMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-279
Closed -$904 – 158
2023
Q4 		$904 Buy
+279
New +$659 ﹤0.01% 721

Other funds holding ARMP

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SWM
SeaCrest Wealth Management Purchase, New York $903M AUM 47.26% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Tennessee Valley Asset Management Partners's ARMP Position: Q1 2024 in Review

Tennessee Valley Asset Management Partners sold out of Armata Pharmaceuticals (ARMP) in Q1 2024, closing a stake of 279 shares — an estimated $904 sold.

Tennessee Valley Asset Management Partners first reported a position in ARMP in Q4 2023 and held it in 1 quarter. The position peaked at $904 in Q4 2023. 24 funds tracked by Wall St. Rank hold ARMP as of Q1 2024.

  • Tennessee Valley Asset Management Partners reported no remaining Armata Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
  • Tennessee Valley Asset Management Partners sold 279 Armata Pharmaceuticals shares in Q1 2024, an estimated $904.
  • Tennessee Valley Asset Management Partners first reported a position in Armata Pharmaceuticals in Q4 2023 and held it in 1 quarter.
  • Tennessee Valley Asset Management Partners's Armata Pharmaceuticals position peaked at $904 in Q4 2023.
  • 24 funds tracked by Wall St. Rank held Armata Pharmaceuticals as of Q1 2024.

Based on Tennessee Valley Asset Management Partners's 13F filing for Q1 2024, filed 23 Apr 2024.